Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,285 total articles

Mink Brook Asset Management Increases DLHC Stake Near 52-Week Low

Mink Brook Asset Management Increases DLHC Stake Near 52-Week Low

Mink Brook Asset Management LLC has executed additional open market purchases of DLH Holdings Corp. (NASDAQ: DLHC) stock, bringing its total beneficial ownership to over 2.1 million shares. The acquisitions occurred over two days in late July 2026, as the stock traded near its 52-week low. Concurrently, DLH Holdings announced significant executive …

Horizon Kinetics Director Acquires Additional RENN Fund Equity Stake

Horizon Kinetics Director Acquires Additional RENN Fund Equity Stake

Horizon Kinetics Asset Management LLC, acting as a director and significant 10% shareholder of RENN Fund, Inc., executed a recent equity acquisition. The firm purchased 756 shares of common stock on July 23, 2026, at a price of $3.06 per share, bringing the total transaction value to $2,313. This purchase increases Horizon Kinetics' direct holdings…

3M Executive Executes Stock Sale Following Option Exercise

3M Executive Executes Stock Sale Following Option Exercise

3M Company (NYSE:MMM) Executive Vice President John Patrick Banovetz executed a stock sale on July 23, 2026, following the exercise of non-qualified stock options. The transaction involved the sale of 7,880 shares at $170.44 per share, generating approximately $1.34 million. This activity occurs as 3M reports strong second-quarter earnings that exc…

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Mir A. Imran, a director and significant shareholder in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), recently executed a purchase of 36,000 shares of the company's Class A Common Stock. This transaction, valued at $24,839, occurred against a backdrop of recent corporate developments, including the announcement of positive initial data from a Pha…

Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum

Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum

Cytokinetics Inc. (NASDAQ: CYTK) Executive Vice President of Research & Development Fady Malik executed a series of transactions on July 21, 2026, selling 3,500 shares of common stock while simultaneously exercising non-qualified stock options to acquire an equal number of shares. The sale was reported at $80.59 per share, totaling $282,065, while …

Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock

Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock

Mary Miller, Chief Legal Officer at Acrivon Therapeutics, Inc. (NASDAQ:ACRV), executed a $1,008 sale of the company's common stock on July 21, 2026. The transaction involved the automatic disposition of 573 shares at $1.76 each to satisfy mandatory tax withholding requirements triggered by the vesting of restricted stock units. Following the transa…

Travelers Executive Michael Klein Executes $2.2 Million Stock Disposition Amid Mixed Analyst Sentiment

Travelers Executive Michael Klein Executes $2.2 Million Stock Disposition Amid Mixed Analyst Sentiment

Michael Frederick Klein, Executive Vice President and President of Personal Insurance at The Travelers Companies, Inc., executed a series of stock transactions on July 21, 2026, resulting in the sale of 6,000 shares valued at approximately $2.2 million. The sales occurred in two separate transactions, with shares sold at weighted average prices of …